Who Owns Calidi Biotherapeutics Stock?
NYSE: CLDIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 10:19 AM ET
Ownership breakdown
- Held by institutions
- 1.00%
- Held by insiders
- 0.61%
- Institutional holders
- 23
- Institutions 1.0%
- Insiders 0.6%
- Public and other 98.4%
Who owns Calidi Biotherapeutics stock?
Institutional investors own about 1.0% of Calidi Biotherapeutics's shares, spread across 23 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.61% of CLDI.
The largest institutional holders are Geode Capital Management, LLC (0.27%), HighTower Advisors, LLC (0.20%) and Jane Street Group, LLC (0.13%). Together, the top 10 institutions control 1.1% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their CLDI positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CLDI
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Geode Capital Management, LLC | 7.16K | 0.27% | +81.8% |
| HighTower Advisors, LLC | 5.22K | 0.20% | 0.0% |
| Jane Street Group, LLC | 3.39K | 0.13% | +56.0% |
| Independent Advisor Alliance | 2.81K | 0.11% | +100.0% |
| Rs Crum Inc. | 2.70K | 0.10% | +7.4% |
| Arax Advisory Partners | 2.33K | 0.09% | 0.0% |
| Private Advisor Group, LLC | 1.88K | 0.07% | +100.0% |
| Vanguard Capital Management LLC | 1.59K | 0.06% | 0.0% |
| Belpointe Asset Management LLC | 1.25K | 0.05% | 0.0% |
| Northern Trust Corporation | 1.11K | 0.04% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CLDI
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 6.33K | 0.24% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.59K | 0.06% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 321 | 0.01% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 290 | 0.01% |
Frequently asked questions
Who is the largest shareholder of Calidi Biotherapeutics?
Geode Capital Management, LLC is the largest institutional shareholder of CLDI, owning 0.27% of shares outstanding (7.16K shares) as of its latest 13F filing.
What percentage of Calidi Biotherapeutics is owned by institutions?
Institutions own about 1.0% of CLDI shares and 1.0% of the public float.
How much of Calidi Biotherapeutics do insiders own?
Insiders, such as officers and directors, own about 0.61% of CLDI shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.